Ablevia - A customizable biotherapeutics format for the selective removal of harmful and disease-causing antibodies.
Country: Austria
Ablevia - A customizable biotherapeutics format for the selective removal of harmful and disease-causing antibodies.
Country: Austria
Ahead Therapeutics - Ahead Therapeutics is a biotechnology company that will put a breakthrough nano-tech platform on the market for treating and curing autoimmune disease.
Country
: Spain
AtmosR develops treatments for patients suffering from CNS disorders with high unmet medical needs.
Country: France
Cellbox Labs have developed unique gut on chip model what is miniature organ replicas to develop drugs and probiotics faster, cheaper and more effective.
Country: Latvia
Countagen is developing quality control tools for gene editing methods to enable and accelerate research and development.
Country: Sweden
Delta biosciences is accelerating drug discovery with a next-gen molecular screening platform that integrates a supra-high picofluidic throughput with directed chemical evolution.
Country: Lithuania
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain using a radically innovative peptide-based patented technology platform.
Country: Spain
Immunyx Pharma is developing next generation drugs for immune modulation with a focus on neutrophils in chronic disease.
Country: Israel
MediSieve is a London-based start-up that has developed Magnetic Blood Filtration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients.
Country: England
One-Carbon Therapeutics AB is tackling the most difficult to treat cancers and autoimmune diseases by targeting the DNA damage response and metabolism using first-in-class drugs.
Country: Sweden
PRAMOMOLECULAR's platform technology silences pathogenic proteins in the lungs, heart, and pancreas - for innovative active ingredients against diseases such as cancer or heart failure.
Country: Germany
StemSight develops off-the-shelf alternatives for donor corneal tissue using allogeneic induced pluripotent stem cells.
Country: Finland
Suil Pharma is restoring independence and quality of life to the millions of patients with retinal diseases by restoring vision lost from diabetic macular oedema, wet macular degeneration and retinal vein occlusion.
Country: Ireland
Torskal cure cancers with ethical gold and are the pioneers in green nanotechnology.
Country: France
Catapult Competition Prizes Sponsors
RUN BY WITH THE SUPPORT OF ORGANISED BY